Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 16Breast Neoplasms 10Brain Neoplasms 7Neoplasms 4Lymphoma, Non-Hodgkin 4Lymphoma 4Urinary Bladder Neoplasms 3Spinal Cord Neoplasms 3Multiple Myeloma 2Lymphoma, B-Cell 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Carcinoma in Situ 2Burkitt Lymphoma 2Vulvar Neoplasms 1Vulvar Diseases 1Vasculitis 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Unspecified Adult Solid Tumor, Protocol Specific 1Thrombocythemia, Essential 1Thoracic Neoplasms 1Thoracic Diseases 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spinal Diseases 1Solid Tumor, Adult 1Sinusitis 1Sarcoma 1

Interventions

pembrolizumab 1Vincristine 1Vinblastine 1Procarbazine 1Prednisone 1Methotrexate 1Mercaptopurine 1Magnetic Resonance Imaging 1Etoposide 1Drug Therapy 1Doxorubicin 1Dexamethasone 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Caspofungin 1BAY 1895344 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Ataxia Telangiectasia × Magnetic Resonance Imaging × Clear all
NCT05252819 2024-02-07

Whole Body MRI for Cancer Surveillance in A-T

University of Nottingham

Completed
32 enrolled

Ataxia Telangiectasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡